Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16785 | 636 | 33.1 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
499 | 3 | MEDICAL ETHICS//INFORMED CONSENT//ETHICS | 22534 |
795 | 2 | INFORMED CONSENT//RESEARCH ETHICS//MEDICAL ETHICS | 12094 |
16785 | 1 | HIV VACCINE TRIALS//HIV VACCINE//WILLINGNESS TO PARTICIPATE | 636 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HIV VACCINE TRIALS | authKW | 1140964 | 6% | 61% | 39 |
2 | HIV VACCINE | authKW | 820319 | 12% | 22% | 76 |
3 | WILLINGNESS TO PARTICIPATE | authKW | 552096 | 4% | 50% | 23 |
4 | VACCINE TRIALS | authKW | 393820 | 3% | 37% | 22 |
5 | HIV AIDS VACCINES ETH GRP | address | 300057 | 2% | 63% | 10 |
6 | AIDS VACCINES | authKW | 270039 | 2% | 38% | 15 |
7 | UNAIDS HIV VACCINE INITIAT | address | 216043 | 1% | 75% | 6 |
8 | HIV VACCINE PREPAREDNESS | authKW | 192041 | 1% | 100% | 4 |
9 | VACCINE PREPAREDNESS | authKW | 153631 | 1% | 80% | 4 |
10 | ACCEPTABILITY OF HEALTHCARE | authKW | 150028 | 1% | 63% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 8534 | 35% | 0% | 220 |
2 | Immunology | 4421 | 40% | 0% | 256 |
3 | Public, Environmental & Occupational Health | 2634 | 27% | 0% | 171 |
4 | Social Sciences, Biomedical | 2628 | 9% | 0% | 55 |
5 | Virology | 2245 | 15% | 0% | 93 |
6 | Mathematical & Computational Biology | 918 | 7% | 0% | 46 |
7 | Health Policy & Services | 909 | 6% | 0% | 41 |
8 | Medicine, Research & Experimental | 825 | 14% | 0% | 91 |
9 | Medical Informatics | 821 | 5% | 0% | 29 |
10 | Statistics & Probability | 692 | 8% | 0% | 54 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HIV AIDS VACCINES ETH GRP | 300057 | 2% | 63% | 10 |
2 | UNAIDS HIV VACCINE INITIAT | 216043 | 1% | 75% | 6 |
3 | HIV AIDS VACCINE ETH GRP | 108022 | 0% | 75% | 3 |
4 | S AFRICAN AIDS VACCINE INITIAT | 96021 | 0% | 100% | 2 |
5 | VACCINE CLIN BRANCH | 80011 | 1% | 33% | 5 |
6 | PL SOCIAL | 74167 | 3% | 9% | 17 |
7 | HIV VACCINE SECT | 64012 | 0% | 67% | 2 |
8 | HLTH SYST GOVERNANCE FINANCE | 64012 | 0% | 67% | 2 |
9 | HOPE CLIN | 49372 | 1% | 17% | 6 |
10 | AIDS IMMUNOSUPP S PROGRAM | 48010 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 23341 | 8% | 1% | 51 |
2 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 23095 | 5% | 2% | 29 |
3 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 16412 | 6% | 1% | 38 |
4 | AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 8980 | 4% | 1% | 25 |
5 | VACCINE | 7429 | 8% | 0% | 53 |
6 | SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE | 5599 | 1% | 2% | 5 |
7 | AIDS & PUBLIC POLICY JOURNAL | 4543 | 0% | 3% | 3 |
8 | STATISTICS IN MEDICINE | 4154 | 4% | 0% | 25 |
9 | SAMJ SOUTH AFRICAN MEDICAL JOURNAL | 3492 | 2% | 1% | 10 |
10 | AIDS | 2670 | 3% | 0% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV VACCINE TRIALS | 1140964 | 6% | 61% | 39 | Search HIV+VACCINE+TRIALS | Search HIV+VACCINE+TRIALS |
2 | HIV VACCINE | 820319 | 12% | 22% | 76 | Search HIV+VACCINE | Search HIV+VACCINE |
3 | WILLINGNESS TO PARTICIPATE | 552096 | 4% | 50% | 23 | Search WILLINGNESS+TO+PARTICIPATE | Search WILLINGNESS+TO+PARTICIPATE |
4 | VACCINE TRIALS | 393820 | 3% | 37% | 22 | Search VACCINE+TRIALS | Search VACCINE+TRIALS |
5 | AIDS VACCINES | 270039 | 2% | 38% | 15 | Search AIDS+VACCINES | Search AIDS+VACCINES |
6 | HIV VACCINE PREPAREDNESS | 192041 | 1% | 100% | 4 | Search HIV+VACCINE+PREPAREDNESS | Search HIV+VACCINE+PREPAREDNESS |
7 | VACCINE PREPAREDNESS | 153631 | 1% | 80% | 4 | Search VACCINE+PREPAREDNESS | Search VACCINE+PREPAREDNESS |
8 | ACCEPTABILITY OF HEALTHCARE | 150028 | 1% | 63% | 5 | Search ACCEPTABILITY+OF+HEALTHCARE | Search ACCEPTABILITY+OF+HEALTHCARE |
9 | PREVENTIVE MISCONCEPTION | 108022 | 0% | 75% | 3 | Search PREVENTIVE+MISCONCEPTION | Search PREVENTIVE+MISCONCEPTION |
10 | VACCINE PREPAREDNESS STUDY | 108022 | 0% | 75% | 3 | Search VACCINE+PREPAREDNESS+STUDY | Search VACCINE+PREPAREDNESS+STUDY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DHALLA, S , POOLE, G , (2011) BARRIERS OF ENROLMENT IN HIV VACCINE TRIALS: A REVIEW OF HIV VACCINE PREPAREDNESS STUDIES.VACCINE. VOL. 29. ISSUE 35. P. 5850 -5859 | 63 | 95% | 10 |
2 | DHALLA, S , (2016) AGE AND SEX OR GENDER (SEX/GENDER) AND HIV VACCINE PREPAREDNESS.PSYCHOLOGY HEALTH & MEDICINE. VOL. 21. ISSUE 4. P. 505 -524 | 46 | 87% | 0 |
3 | DHALLA, S , POOLE, G , (2011) MOTIVATORS OF ENROLMENT IN HIV VACCINE TRIALS: A REVIEW OF HIV VACCINE PREPAREDNESS STUDIES.AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. VOL. 23. ISSUE 11. P. 1430-1447 | 43 | 93% | 11 |
4 | DHALLA, S , POOLE, G , (2015) SOCIOECONOMIC STATUS AND HIV VACCINE PREPAREDNESS STUDIES IN NORTH AMERICA.VACCINE. VOL. 33. ISSUE 22. P. 2536 -2545 | 36 | 90% | 0 |
5 | LAU, CY , STANSBURY, JP , GUST, DA , KAFAAR, Z , (2009) SOCIAL AND BEHAVIORAL SCIENCE IN HIV VACCINE TRIALS: A GAP ASSESSMENT OF THE LITERATURE.EXPERT REVIEW OF VACCINES. VOL. 8. ISSUE 2. P. 179-190 | 48 | 62% | 3 |
6 | NEWMAN, PA , LOGIE, C , (2010) HIV VACCINE ACCEPTABILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS.AIDS. VOL. 24. ISSUE 11. P. 1749 -1756 | 33 | 77% | 28 |
7 | DHALLA, S , WOODS, R , STRATHDEE, SA , PATRICK, DM , HOGG, RS , (2007) HIV VACCINE PREPAREDNESS STUDIES IN THE ORGANIZATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (OECD) COUNTRIES.AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. VOL. 19. ISSUE 9. P. 1118-1127 | 28 | 100% | 19 |
8 | DHALLA, S , POOLE, G , (2014) EFFECT OF RACE/ETHNICITY ON PARTICIPATION IN HIV VACCINE TRIALS AND COMPARISON TO OTHER TRIALS OF BIOMEDICAL PREVENTION.HUMAN VACCINES & IMMUNOTHERAPEUTICS. VOL. 10. ISSUE 7. P. 1974 -1984 | 37 | 65% | 1 |
9 | YOUNG, AM , DICLEMENTE, RJ , HALGIN, DS , STERK, CE , HAVENS, JR , (2014) DRUG USERS' WILLINGNESS TO ENCOURAGE SOCIAL, SEXUAL, AND DRUG NETWORK MEMBERS TO RECEIVE AN HIV VACCINE: A SOCIAL NETWORK ANALYSIS.AIDS AND BEHAVIOR. VOL. 18. ISSUE 9. P. 1753 -1763 | 29 | 81% | 3 |
10 | DHALLA, S , NELSON, K , SINGER, J , POOLE, G , (2009) HIV VACCINE PREPAREDNESS STUDIES IN THE NON-ORGANIZATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT (NON-OECD) COUNTRIES.AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV. VOL. 21. ISSUE 3. P. 335 -348 | 32 | 76% | 9 |
Classes with closest relation at Level 1 |